Esmeron Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Rocuronium Br

Indications/Uses

Adjunct to general anesth to facilitate endotracheal intubation, to provide skeletal muscle relaxation during surgery & to facilitate mechanical ventilation in adults, childn & infants from 1 mth. Adjunct in ICU to facilitate mechanical ventilation as part of Rapid Sequence Induction in adults.

Click to view Esmeron detailed prescribing information

Dosage/Direction for Use

Tracheal intubation: 0.6 mg/kg. Maintenance: 0.15 mg/kg. Long-term inhalation anaesth: Reduce to 0.075-0.1 mg/kg. Maintenance doses should best be given when twitch height has recovered to 25% of control twitch height. Continuous infusion: 0.6 mg/kg loading dose. Geriatric & patient w/ hepatic, biliary &/or renal failure 0.6 mg/kg. Maintenance: 0.075-0.1 mg/kg.

Click to view Esmeron detailed prescribing information

Overdosage

View Esmeron overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view Esmeron detailed prescribing information

Special Precautions

Anaphylaxis. CV disease, oedematous state; neuromuscular disease, poliomyelitis; hypothermia; obesity; burns; hypokalaemia, hypermagnesemia, hypocalcemia, hypoproteinemia, dehydration, acidosis, hypercapnia, cachexia. Residual curarization. Long-term use in ICU setting. Concomitant use w/ corticosteroids; suxamethonium. May affect ability to drive & use machines. Hepatic &/or biliary tract disease; renal failure. Pregnancy & lactation. Elderly.

Click to view Esmeron detailed prescribing information

Use In Pregnancy & Lactation

Click to view Esmeron detailed prescribing information

Adverse Reactions

Anaphylactic & anaphylactoid reactions. Inj site pain/reaction, changes in vital signs, prolonged neuromuscular block.

Click to view Esmeron detailed prescribing information

Drug Interactions

Increased effects w/ halogenated volatile anesth, suxamethonium, corticosteroids; aminoglycoside, lincosamide, polypeptide & acylamino-penicillin antibiotics; diuretics, quinidine, quinine, Mg salts, Ca-channel blockers, lithium salts, local anesth (lidocaine IV, bupivacaine epidural), acute administration of phenytoin or β-blockers. Decreased effects w/ phenytoin or carbamazepine; PIs eg, gabexate, ulinastatin. Potentiated or attenuated neuromuscular blocking effects w/ other non-depolarizing neuromuscular blockers, suxamethonium. Quicker onset of action of lidocaine.

Click to view Esmeron detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Esmeron detailed prescribing information

Storage

View Esmeron storage conditions for details to ensure optimal shelf-life.

Description

View Esmeron description for details of the chemical structure and excipients (inactive components).

Action

View Esmeron mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Neuromuscular Blocking Agents

ATC Classification

M03AC09 - rocuronium bromide ; Belongs to the class of other quaternary ammonium-containing agents used as peripherally-acting muscle relaxants.

Regulatory Classification

Presentation/Packing

Form

Esmeron soln for inj (vial) 50 mg/5 mL

Packing/Price

10 × 1's

Esmeron

rocuronium bromide

Manufacturer:

Merck Sharp & Dohme

Distributor:

Zuellig Pharma